HSA and FSA Eligibility for Ketamine Therapy Costs

Yes, ketamine therapy is generally an eligible expense for Health Savings Accounts (HSAs) and Flexible Spending Accounts (FSAs) when a licensed clinician prescribes it to treat a diagnosed condition, such as treatment-resistant depression, generalized anxiety, or post-traumatic stress disorder (PTSD). The Internal Revenue Service (IRS) doesn't maintain a list naming ketamine specifically. Eligibility flows from Section 213(d) of the federal tax code, which defines a qualified medical expense as an amount paid for the diagnosis, cure, mitigation, treatment, or prevention of disease. Because ketamine is a legally prescribed drug, whether administered as the FDA-approved esketamine nasal spray (Spravato) or as generic ketamine prescribed off-label, treatment costs typically meet that standard. Where people run into trouble is documentation: your plan administrator, not the IRS directly, decides what proof it needs before releasing your funds.

How the IRS Defines a Qualified Medical Expense

According to IRS Publication 502, medical expenses eligible for HSA or FSA reimbursement include amounts paid for prescribed medicine and drugs and for treatment affecting any part or function of the body. Ketamine, first approved by the FDA as an anesthetic in 1970, meets the definition of a prescribed drug when a licensed clinician orders it for a specific diagnosis. That's true whether it's dispensed as a nasal spray, an intravenous infusion, or a sublingual tablet taken at home. The tax code doesn't distinguish between FDA-approved and off-label use of an already-approved drug; it asks whether the expense was primarily for medical care rather than for general health or personal well-being.

FDA-approved esketamine vs. off-label generic ketamine

Esketamine (brand name Spravato) is the only ketamine-derived treatment with FDA approval, specifically for treatment-resistant depression in adults, and it's typically billed through standard medical insurance codes. If your insurance covers part of the cost, your copay or coinsurance is almost always HSA/FSA eligible because the claim already carries an insurance-verified diagnosis and procedure code. Generic ketamine, used for depression, anxiety, PTSD, and some chronic pain conditions, is prescribed off-label, meaning the FDA hasn't approved it for those specific uses even though the drug itself is FDA-approved and legal to prescribe. Off-label prescribing is common in medicine and doesn't disqualify an expense from HSA/FSA reimbursement, but because it's less standardized, your administrator is more likely to ask for a letter of medical necessity before approving the claim. For a deeper look at how the two options differ in evidence, cost, and delivery, see our comparison of generic ketamine vs spravato and our breakdown of ketamine vs. esketamine.

What HSA and FSA Funds Typically Don't Cover

Tax-advantaged accounts are built for medical care, not general wellness, and administrators apply that line more strictly to newer or less standardized treatments. Expenses that commonly get denied or flagged include:

• Membership or concierge fees for a clinic that aren't tied to a specific, itemized medical service
• Coaching-only or integration-circle sessions led by staff who aren't licensed clinicians, unless billed as part of documented psychotherapy
• Wellness supplements or add-ons marketed alongside ketamine but not prescribed for your diagnosis
• Travel and lodging beyond the limited mileage and lodging allowances the IRS permits for medical travel

Regulators have also scrutinized how some online ketamine sellers market and screen patients for at-home use; our coverage of that federal investigation is useful background if you're evaluating a telehealth provider, since offerings that look more like a subscription wellness product than licensed medical care are the ones most likely to run into HSA/FSA documentation problems. Comparing delivery models side by side, including telehealth ketamine vs in-clinic treatment, can help you spot which providers bill and document treatment the way your plan administrator expects.

How This Fits Into the Bigger Cost Picture

Ketamine treatment costs vary widely by setting and format. In-clinic intravenous ketamine typically runs several hundred dollars per session, with a full course of six or more sessions reaching into the thousands of dollars; at-home sublingual or oral telehealth programs are often priced lower per session but still add up over a multi-week course. Esketamine (Spravato) is usually billed through medical insurance rather than paid entirely out of pocket, so your HSA/FSA role there is typically limited to your copay, coinsurance, or deductible. Because most insurance plans still treat generic ketamine as an off-label, largely self-pay treatment, HSA and FSA funds are often the main way patients offset that cost. Pairing that budget planning with a clear understanding of the evidence for your specific condition, such as how ketamine compares to standard ketamine vs. antidepressants options, helps you judge whether the expense fits your situation. Before you commit funds, review the clinical and screening questions in our guide to ketamine treatment eligibility and confirm your prescriber's credentials using steps like those in verifying a ketamine provider's medical license.

This article is educational and doesn't replace advice from a licensed tax professional or your HSA/FSA plan administrator, whose specific rules control your reimbursement. It also isn't medical advice: talk with a licensed clinician about whether ketamine therapy fits your diagnosis and treatment history before you commit funds to a course of treatment.